Connecting clinical care, data and research
PartnershipsContact
← Back to publications

RESEARCH PUBLICATION / 2026

Original Article

GLP-1 drugs and macular degeneration in elderly and obese subjects without diabetes

GLP-1 Receptor Agonists and Risk of Age-Related Macular Degeneration in Older Adults With Obesity: A Target Trial Emulation.

Diabetes, obesity & metabolism

Citation & Authors

Diabetes Obes Metab. 2026;28(8):6973-6984.

Tsung Wei Chang; Chia-Yu Kuo; Chris Yuan-Hao Lee; Cheng-Hsien Hung

ABSTRACT · RESEARCH SUMMARY

Research summary

This target trial emulation matched 78,940 patients per group, all aged ≥60 years with obesity but without diabetes. Compared with other weight-loss medications, GLP-1 drugs were associated with a lower risk of incident AMD (HR 0.82; 95% CI 0.68–0.98). Median follow-up differed between groups, and subgroup findings were exploratory. Direct drug effects cannot yet be distinguished from the influence of the amount of weight lost.

Key points based on the public abstract; this is a reading guide, not a full abstract translation.Read original abstract ↗